NovoCure Files 8-K for May 2025
Ticker: NVCR · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1645113
| Field | Detail |
|---|---|
| Company | Novocure Ltd (NVCR) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-disclosure, regulation-fd
Related Tickers: NVCR
TL;DR
NovoCure filed its 8-K for May 31, 2025, updating corporate info and disclosures.
AI Summary
NovoCure Limited filed an 8-K on May 31, 2025, reporting under Regulation FD and including financial statements and exhibits. The filing details the company's principal executive offices located at No. 4 The Forum, Grenville Street, St. Helier, Jersey JE2 4UF, with a business phone number of +44 (0) 15 3475 6700. The report covers the period ending May 31, 2025.
Why It Matters
This 8-K filing provides an update on NovoCure's corporate information and regulatory disclosures as of May 31, 2025.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- NovoCure Limited (company) — Registrant
- No. 4 The Forum, Grenville Street, St. Helier, Jersey JE2 4UF (location) — Principal Executive Offices
- +44 (0) 15 3475 6700 (phone_number) — Business Phone
- May 31, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report under Regulation FD Disclosure and to include Financial Statements and Exhibits as of May 31, 2025.
What is NovoCure Limited's principal executive office address?
NovoCure Limited's principal executive offices are located at No. 4 The Forum, Grenville Street, St. Helier, Jersey JE2 4UF.
What is the business phone number listed for NovoCure Limited?
The business phone number listed for NovoCure Limited is +44 (0) 15 3475 6700.
What is the date of the report for this 8-K filing?
The date of the report for this 8-K filing is May 31, 2025.
What is the Commission File Number for NovoCure Limited?
The Commission File Number for NovoCure Limited is 001-37565.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding NovoCure Ltd (NVCR).